SLC5A2 and acute kidney injury: Furthermore, SGLT2 inhibitors improve haemodynamics and exhibit anti-inflammatory properties.12 13 Preclinical data have shown that SGLT2 inhibitors reduced renal ischaemia-reperfusion injury.14, 16 An overview of the proposed advantages of SGLT2 inhibitors in reducing CSA-AKI is shown in figure 1.